Skip to main content
. 2024 Feb 29;36(1):25–35. doi: 10.21147/j.issn.1000-9604.2024.01.03

Table 1. Clinicopathologic features of 220 patients with distant metastatic differentiated thyroid cancer.

Clinicopathologic features n (%) P
Non-RAIR (N=81) RAIR-DTC (N=139)
IQR, interquartile range; PTC, papillary thyroid cancer; FTC, follicular thyroid cancer; PDTC, poorly differentiated thyroid cancer; T, tumor; N, lymph node; RAIR, radioactive iodine-refractory; RAIR-DTC, radioactive iodine-refractory differentiated thyroid cancer; *, Part of data are not available; a, Brain, liver, pancreas, pleura, muscle, or distant metastatic lymph nodes, with or without lung and bone metastases.
Age at diagnosis (year) [median (IQR)] 34.15 (28.80, 41.72) 46.72 (35.27, 56.13) <0.001
Gender: female 51 (63.0) 78 (56.1) 0.320
Pathology 0.441
 PTC 74 (91.4) 118 (84.9)
 FTC 5 (6.2) 12 (8.6)
 PTC and FTC 1 (1.2) 2 (1.4)
 PDTC 1 (1.2) 7 (5.0)
T stage* 0.064
 1−3a 47 (63.5) 58 (46.8)
 3b−4b 27 (36.5) 66 (53.2)
N stage* 0.145
 0 11 (14.1) 11 (8.9)
 1a 5 (6.4) 10 (8.1)
 1b 62 (79.5) 102 (82.9)
Distant metastatic organs 0.004
 Lung 69 (85.2) 96 (69.1)
 Bone 3 (3.7) 5 (3.6)
 Lung and bone 8 (9.9) 14 (10.1)
 Othersa 1 (1.2) 24 (17.3)
Mutational load [median (IQR)] 1 (1, 2) 2 (1, 2) <0.001